Mylan to commercialise Fujifilm’s Humira biosimilar in Europe
Fujifilim Kyowa Kirin Biologics has teamed up with Mylan for the commercialisation of its Humira (adalimumab) biosimilar, FKB327.
Archives for April 11, 2018
UPDATE
Amgen picks Rhode Island location for next-gen biomanufacturing
Rhode Island will be the home of Amgen’s first US next-generation biomanufacturing plant, based on the firm’s modular, single-use site in Singapore.
Stellar ups aquaculture on demand for limpet protein used in vaccine production
Demand for a protein produced from a marine mollusk used as a carrier molecule in therapeutic vaccines has driven Stellar Biotech to expand a facility in LA.